Inflammasome Reports Success In Eye Treatment Clinical Trial
15 Jan 2025 //
BUSINESSWIRE
Halia To Present HT-6184 Phase II Data At Inflammasome Summit
10 Sep 2024 //
PR NEWSWIRE
Inflammasome Completes Enrollment For Dual Inhibitor Study
10 Sep 2024 //
BUSINESSWIRE
Inflammasome Announces First Patient Dosed in Ph I Diabetic Macular Edema Study
18 Jan 2024 //
BUSINESSWIRE
Inflammasome to Develop Dual Sustained-Release HIV Prevention Implant
09 Aug 2021 //
BUSINESSWIRE